ArticleCancer discovery2022

Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.

Meng-Ju Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.